The promise of precision medicine is replacing the one-size-fits-all medicine of the past. Doctors hope this will make everyone healthier. But a new report says certain groups in the US are in jeopardy of being worse off when medicine is tailor-made. Who stands to lose?
Researchers have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukaemia would relapse following treatment.
Researchers have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. Following safety studies, a human clinical trial could be less than two years away.
Scientists created an odd couple: a modified version of an immune-signalling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.
Genetically engineered cancer-killing T-cells can hunt and attack brain tumours that display a new molecular target that is highly prevalent on brain cancer cells, report researchers
Babies with the deadly genetic disorder Sandhoff disease begin to miss developmental milestones months after birth, but new research describes step towards gene therapy to help.
Patients with a variety of advanced cancers occurring in different sites of the body have trialed a larotrectinib, with three-quarters of patients, both adults, and children responding to the drug.
Light-activated cancer drugs that don’t cause the toxic side effects of current chemotherapy treatments are closer to becoming a reality, a new study suggests.
Britain’s Oxford BioMedica has a lot to be happy about right now, since its win in a second $100 million contract to supply gene therapy material from Bioverativ.
Researchers have found a structure on the small viruses that deliver gene therapy that makes them better at crossing from the bloodstream into the brain.
Researchers have identified a new stem cell pathway that allows a highly aggressive form of breast cancer—triple-negative breast cancer—to thrive.
New findings point to a technique that uses specially designed nanoparticles and near-infrared laser treatment to cause cancer cells to lose their multidrug resistance capabilities for days at a time.
Reading the whole genetic blueprint of a fetus long before birth could become a routine procedure thanks to a new blood test.
Scientists have developed a new system to rapidly determine which cancer drugs are likely to work best given a patient’s genetic markers.